Table 2.

 Uptake of thrombolysis and secondary prophylactic drug treatment in men and women

Treatment	Men (n = 821)	Women (n = 458)	Unadjusted OR (95% CI)	p Value	Adjusted OR (95% CI)	p Value
Thrombolysis*	485 (50.6)	259 (43.8)	0.76 (0.62 to 0.93)	0.009	0.93 (0.75 to 1.16)	0.52
ACE inhibitors	427 (52.0)	227 (49.6)	0.91 (0.72 to 1.14)	0.40	0.85 (0.66 to 1.08)	0.18
Statins	196 (23.8)	109 (23.8)	1.00 (0.76 to 1.30)	0.99	1.48 (1.10 to 1.98)	0.0092
Aspirin	741 (90.3)	397 (86.7)	0.70 (0.49 to 1.00)	0.051	0.90 (0.62 to 1.32)	0.60
β Blockers	401 (48.8)	174 (38.0)	0.64 (0.51 to 0.81)	0.0002	0.78 (0.60 to 1.00)	0.051

Data are number (%) of patients. Odds ratios (OR) are for the ratio of women to men with 95% confidence intervals (CI) and associated p values. Adjustment was for age and for all other covariates in table 1.

*Thrombolysis analysis based on all patients at admission. Prescription of secondary prophylactic drug treatment was for those surviving to hospital discharge.

ACE, angiotensin converting enzyme.